BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 17, 2008
View Archived Issues
Blocking Heat Shock Proteins Points to More Selective Drugs
Read More
Unibioscreen Gets Up to $31M in Cancer Drug Deal with Drais
Read More
NicOx Shows Positive Data From 2nd Naproxcinod Trial
Read More
Polyplus-transfection Develops New Class of Oligonucleotides
Read More
Biomarker Data Point to Target Patients for Transgene's Vaccine
Read More
CV Therapeutics Gets $70M Up Front in Ex-U.S. Ranexa Deal
Read More
Other News To Note
Read More
Cell Medica Begins Study of CMV Transplant Therapy
LONDON - Cell Medica Ltd. has treated the first patient in a Phase III trial of a cell therapy treatment for the prevention of cytomegalovirus (CMV) infection in immunocompromised bone marrow transplant patients. (BioWorld International)
Read More
HemoCORM, Alfama Align in Carbon Monoxide Deal
Read More